(19)
(11) EP 2 349 319 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
04.04.2018 Bulletin 2018/14

(45) Mention of the grant of the patent:
20.12.2017 Bulletin 2017/51

(21) Application number: 09761019.0

(22) Date of filing: 19.11.2009
(51) International Patent Classification (IPC): 
A61K 38/17(2006.01)
 C12Q 1/25(2006.01)
(86) International application number:
PCT/IB2009/055181
(87) International publication number:
WO 2010/058364 (27.05.2010 Gazette 2010/21)

(54)

USE OF PROTEINS OF DJ-1 TYPE FOR CHARACTERIZING SKIN DRYNESS

VERWENDUNG VON PROTEINEN DES DJ-1 TYPS ZUR CHARAKTERISIERUNG VON HAUTTROCKENHEIT

UTILISATION DE PROTÉINES DE TYPE DJ-1 POUR LA CARACTÉRISATION D'UNE SÉCHERESSE CUTANÉE

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

(30) Priority: 21.11.2008 FR 0857916
03.12.2008 US 193486 P

(43) Date of publication of application:
03.08.2011 Bulletin 2011/31

(73) Proprietor: L'Oreal
75008 Paris (FR)

(72) Inventors:
  • BERNARD, Dominique
    F-92170 Vanves (FR)
  • SIMONETTI, Lucie
    F-94300 Vincennes (FR)
  • CASTIEL, Isabelle
    F-06200 Nice (FR)

(74) Representative: Nony 
11 rue Saint-Georges
75009 Paris
75009 Paris (FR)


(56) References cited: : 
WO-A-03/024302
   
  • EL GHALBZOURI A ET AL: "Fibroblasts facilitate re-epithelialization in wounded human skin equivalents" LABORATORY INVESTIGATION 2004 GB, vol. 84, no. 1, 2004, pages 102-112, XP002547901 ISSN: 0023-6837 1530-0307
  • NAGAKUBO D ET AL: "DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras" BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 19970213 US, vol. 231, no. 2, 13 February 1997 (1997-02-13), pages 509-513, XP002547902 ISSN: 0006-291X
  • TAO X ET AL: "Crystal structure of human DJ-1, a protein associated with early onset Parkinson's disease" JOURNAL OF BIOLOGICAL CHEMISTRY 20030815 US, vol. 278, no. 33, 15 August 2003 (2003-08-15), pages 31372-31379, XP002547903 ISSN: 0021-9258
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).